🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 60458C104
- IPO
- 8/3/2023 · $7.00/share
Business: MIRA Pharmaceuticals, Inc. is a preclinical-stage pharmaceutical company focused on the development and commercialization of new molecular synthetic cannabinoid analog for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia.
Company Contact
- CEO
- Erez Aminov
- CFO
- Michelle Yanez
- Headquarters
- 1200 Brickell Avenue, Suite 1950 #1183, Miami, FL 33131
- Phone
- 786-432-9792
- Investor Relations
- Michael Kim, MZ North America · 737-289-0835 · info@mirapharma.com